The UK’s proposed regulations would provide the legal framework for POC manufacturing of cell therapies, including quality assurance.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback